Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Clinical Trial the Immunogenicity and Safety Study of A Group A, C Polysaccharide Meningococcal and Type b Haemophilus Influenzal Conjugate Vaccine in Infants and Children.

NCT01428908 is registered in ClinicalTrials.gov with Jiangsu Province Centers for Disease Control and Prevention as lead sponsor.

NCT NCT01428908
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01428908 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Clinical Trial the Immunogenicity and Safety Study of A Group A, C Polysaccharide Meningococcal and Type b Haemophilus Influenzal Conjugate Vaccine in Infants and Children.
Lead sponsor
Jiangsu Province Centers for Disease Control and Prevention
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2011
Completion date
January 31, 2012
Enrollment
2,394 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

group a, c polysaccharide meningitis, type b haemophilus influenza